|
Personal data - diagnosis
|
Personal data
| Visible name: |
Franzlxaver |
| Ctry: |
Deutschland |
| State/Province: |
Rheinland-Pfalz |
| Year of birth: |
1967 |
| Age: |
57 |
| Occupation: |
|
| Hobbies: |
|
| My Website: |
|
|
Data at initial diagnosis
| Date: |
12.10.2012 |
| Age at diagnosis: |
45 |
| PSA: |
14.60 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
4 + 3 = 7b |
| TNM-Stages: |
|
| Remark: |
|
|
|
Maximum measured prostate volume
| Date: |
|
| PSA: |
|
| Volume in ml or cm³: |
|
|
Postoperative pathological data
| Date: |
28.03.2013 |
| Gleason Score: |
3 + 5 = 8 |
| pTNM-classification: |
pT3a pN0 |
| Margins: |
R0 |
| p-L-V-P-G-Findings: |
L1 V1 Pn1 G3 |
| See stories of: |
25.04.2013 |
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
25.03.13 |
|
10.70 |
DaVinci |
Siloah |
Pforzheim |
|
27.08.14 |
|
0.28 |
Open surgery |
RWTH |
Aachen |
|
16.08.17 |
|
1.14 |
Open surgery |
Uniklinik |
Köln |
|
17.11.17 |
|
4.08 |
ADT1 |
|
@Home |
|
19.12.17 |
14.10.22 |
1.33 |
ADT1 |
|
@Home |
|
03.01.18 |
09.05.18 |
1.74 |
Chemotherapy |
6x im Städtischen Klinikum |
Karlsruhe |
|
16.12.19 |
|
3.40 |
other treatments |
Städt. Klinikum Karlsruhe |
Lu177 |
|
17.02.20 |
|
2.18 |
other treatments |
Städt. Klinikum Karlsruhe |
Lu177 (2. Gabe) |
|
14.03.20 |
|
1.40 |
other treatments |
Städt. Klinikum Karlsruhe |
Lu177 (3. Gabe) |
|
21.12.20 |
|
4.89 |
other treatments |
Städt. Klinikum KA |
4. Lu |
|
16.02.21 |
|
3.49 |
other treatments |
Städt. Klinikum KA |
5. Lu |
|
01.06.21 |
07.02.22 |
4.88 |
other treatments |
Zytiga |
@Home |
|
09.02.22 |
25.05.22 |
33.09 |
Chemotherapy |
6x im Städt. Kliikum |
Karlsruhe |
|
15.08.22 |
16.11.22 |
50.78 |
other treatments |
Xtandi (Enzalutamid) |
@Home |
|
04.10.22 |
|
58.53 |
other treatments |
Städt. Klinikum KA |
6. Lu177 |
|
13.12.22 |
22.12.22 |
93.70 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
09.01.23 |
18.01.23 |
108.00 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
14.02.23 |
23.02.23 |
141.00 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
21.03.23 |
30.03.23 |
189.00 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
02.05.23 |
10.05.23 |
222.00 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
22.05.23 |
31.05.23 |
212.00 |
other treatments |
Charité BF Berlin |
CCR1 Studie (Phase 1) |
|
26.06.23 |
24.07.23 |
180.00 |
other RT |
Städt. Klinikum KA |
Karlsruhe |
|
19.10.23 |
|
185.00 |
ADT1 |
@home |
Trenantone (alle drei Monate) |
|
08.11.23 |
|
225.00 |
Chemotherapy |
Städt. Klinikum KA |
Cabazitaxel (alle 2 Wochen) |
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
17.11.17 |
27.12.17 |
Bicalutamid150 |
1x pro Tag |
|
19.12.17 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
30.12.17 |
|
Dekristol 20.000 |
1x pro Woche |
|
17.02.18 |
|
Calcium D3 acis 1000 mg/ 880 i.E |
2x pro Woche |
|
19.02.18 |
|
Denosumab / Xgeva |
zunächst 1x pro Monat |
|
19.03.18 |
|
Denosumab / Xgeva |
|
|
26.03.18 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
30.04.18 |
|
Denosumab / Xgeva |
|
|
01.06.18 |
|
Glucosamin + Chondroitin |
täglich 750 / 600 mg zur Gelenkunterstützung |
|
01.06.18 |
|
Seefischöl |
täglich 1000 mg zur Gelenkunterstützung |
|
27.06.18 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
07.08.18 |
|
Denosumab / Xgeva |
1x pro Quartal |
|
08.10.18 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
23.11.18 |
|
Denosumab / Xgeva |
1x pro Quartal |
|
18.01.19 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
07.03.19 |
|
Xgeva |
1x pro Quartal |
|
10.05.19 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
07.06.19 |
|
Xgeva |
1x pro Quartal |
|
16.08.19 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
17.09.19 |
|
Xgeva |
1x pro Quartal |
|
26.11.19 |
|
Trenantone 11,25mg |
1x pro Quartal |
|
18.05.20 |
|
Trenantone 11,25mg |
1x pro Quartal (in 02/2020 ausgesetzt wegen Lu-Gabe) |
|
01.05.21 |
|
Zytiga |
2x500 morgens (1.000 pro Tag) |
Quantity per D / M / Y etc.
|
